Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Placebo Controlled, Double Blind, Randomised, 8-week Phase IIa Proof of Concept Study to Assess the Efficacy and Safety of AKR 202 in Patients With Osteoarthritis Pain
- First Posted Date
- 2013-12-06
- Last Posted Date
- 2014-10-23
- Lead Sponsor
- Akron Molecules AG
- Target Recruit Count
- 266
- Registration Number
- NCT02003118
- Locations
- 🇦🇹
Clinical study center, Vienna, Austria
News
No news found